ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1625

Association of HLA-B Type and Sacroiliitis in Patients with Psoriatic Arthritis

Daniel Kuo1, Isela Valera2, Mihaela Taylor1, Roy Altman1, Veena K. Ranganath1, Thanda Aung1, James Louie1 and Suzanne Kafaja1, 1Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, 2Autoimmunity and Tolerance Laboratory, Division of Rheumatology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: human leukocyte antigens (HLA), phenotypes and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Psoriatic arthritis (PsA) is a heterogeneous disease with strong genetic heritability. Class I major histocompatibility complex (MHC) genes have been associated with PsA phenotype (1), though data is limited. The goal of this study was to establish the frequency of human leukocyte antigen (HLA)-B alleles in patients with PsA at our center and evaluate associations of allele frequency with radiographic sacroiliitis and other clinical features of PsA.

Methods:

This was a retrospective observational study of patients with PsA at a tertiary academic medical center where patients were identified by ICD code and confirmed to have PsA by an experienced treating rheumatologist. Patients with HLA-B locus testing by reverse sequence specific oligonucleotide (SSO) hybridization were included in the study. Background demographics including age, sex, and ethnicity as well as available radiographs of the sacroiliac joints and MRI exams of the pelvis were collected. Clinical features of psoriatic skin disease, dactylitis, enthesitis, uveitis, and nail disease were also noted. Frequencies of HLA-B alleles were calculated for PsA patients with and without sacroiliitis, then compared to estimates from the general population based on ethnic mix (2). Associations between HLA-B alleles and sacroiliitis on imaging were evaluated with Fisher’s exact test

Results:

We identified 234 patients using ICD coding for psoriatic arthritis from outpatient visits with the treating rheumatologist. Of those, 89 patients did not have HLA-B locus testing and were excluded.   146 PsA patients  were included in the study with mean age 48.6 ± 13.5 years, 56.8% female, 76.7% Caucasian, 8.2% Asian, 7.5% Hispanic, and 1.4% African American. The most common HLA-B alleles amongst PsA patients were HLA-B*35, B*44, B*8, B*7, B*27, and B*38 (Figure 1). X-rays of the sacroiliac joints were available in 86 patients, with 11 cases of radiographic sacroiliitis (12.8%). MRI of the pelvis was available in 25 patients, with 8 cases of sacroiliitis found (six previously noted on x-ray, and two pre-radiographic). Among patients with imaging-proven sacroiliitis, HLA-B*35, B*8, and B*38 were the most common alleles and significantly associated with sacroiliitis (p = 0.03).

Conclusion:

In patients with psoriatic arthritis, HLA-B alleles B*35, B*8, and B*38 may be associated with sacroiliitis. Further larger studies would be helpful in determining the role of HLA-B gene subtypes as predictors of disease features in psoriatic arthritis.

Reference:

1.    Haroon M, et al. Ann Rheum Dis 2016;75:155-162

2.    Maiers M, et al. Hum Immunol 2007;68(9):779-88

Figure 1

Figure 2

 


Disclosure: D. Kuo, None; I. Valera, None; M. Taylor, Celgene Corporation, 8,AbbVie Inc., 8; R. Altman, Ferring, 5,Flexion, 5,GlaxoSmithKline, 5,Novartis, 5,Olatec, 5,Pfizer, Inc., 5; V. K. Ranganath, Genentech, Inc., 2,Pfizer, Inc., 2,mallinkrodt, 2,Amgen Inc., 5; T. Aung, None; J. Louie, Novartis, 5,Eli Lilly and Co., 5,AbbVie Inc., 5,AbbVie Inc., 8,Amgen Inc., 8,Pfizer, Inc., 8; S. Kafaja, None.

To cite this abstract in AMA style:

Kuo D, Valera I, Taylor M, Altman R, Ranganath VK, Aung T, Louie J, Kafaja S. Association of HLA-B Type and Sacroiliitis in Patients with Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/association-of-hla-b-type-and-sacroiliitis-in-patients-with-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-hla-b-type-and-sacroiliitis-in-patients-with-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology